School of Medicine
Showing 51-71 of 71 Results
-
Varsha Rajesh
Research Associate in Functional Genomics, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional at Translational Genomics of Diabetes Lab.
-
David Scheinker
Clinical Professor, Pediatrics - Endocrinology and Diabetes
BioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.
Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students. -
Sejal Shah
Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Seth Andrew Sharp
Postdoctoral Scholar, Endocrinology and Metabolism
BioSeth is a Larry L. Hillblom Postdoctoral Fellow in the Translational Genomics of Diabetes laboratory under Dr. Anna Gloyn with co-mentorship in statistical and population genetics from Dr. Manuel Rivas. Seth completed a B.E. in Applied Mathematics before studying a PhD at the University of Exeter with Drs. Richard Oram and Michael Weedon in which he spent significant time at the Pacific Northwest Research Institute developing new statistical models for polygenic risk scores to predict, screen and understand Type 1 diabetes and other autoimmune disorders with screening expert Dr. William Hagopian. Seth was further seconded to the Alan Turing Institute in London where he used deep learning methods to develop neonatal blood spot polygenic risk screening panels. His postdoctoral studies at Stanford now focus on applying "GWAS-in-a-Dish' and "Polygenic Risk Score to Function (PRS2F)' approaches with rich cellular phenotyping from human donor islets to understand the molecular determinants of impaired insulin secretion in diabetes. He is involved in a number of national human islet research networks and gene-perturbation screen efforts aimed at better understanding diabetes, as well as clinical translation studies at Stanford aimed at improving precision medicine approaches to diabetes.
-
Diane Stafford
Clinical Professor, Pediatrics - Endocrinology and Diabetes
BioDr. Stafford specializes in Pediatric Endocrinology with special interest in disorders of puberty and Prader-Willi syndrome (PWS). Her research interests include in medical education curriculum development, faculty development and endocrine dysfunction in PWS.
-
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Jacqueline Sunderland
Adm Assoc 4, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate, Pediatric Endocrinology & Diabetes
-
Molly Tanenbaum
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Assistant Professor (By courtesy), Pediatrics - Endocrinology and DiabetesBioDr. Tanenbaum is a clinical researcher committed to improving health and quality of life outcomes for people with diabetes. Dr. Tanenbaum’s research focuses on two main areas: 1) understanding and optimizing the role of technology (e.g. mobile technology/mHealth, diabetes devices, closed-loop systems), and the feedback technology provides, to improve diabetes management; and 2) understanding the emotional experience of living with diabetes. Her recent work has focused on developing a telehealth-based behavioral intervention for adults with type 1 diabetes to support adoption and sustained use of continuous glucose monitoring technology. She has expertise in using qualitative and mixed methods to take a human centered approach to understanding the context of living with and managing a chronic condition. Dr. Tanenbaum also has an interest in compassion-based approaches to addressing diabetes distress. As a licensed clinical psychologist, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.
-
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
Darrell Wilson
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.
-
Dessi Zaharieva
Instructor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsThe 4T (Teamwork, Targets, Technology, and Tight Control) Exercise Study focuses on addressing the attitudes & barriers to exercise for families and newly diagnosed youth with type 1 diabetes (T1D). We are currently establishing feasibility and understanding physical activity patterns and behaviours in newly diagnosed youth with T1D using wearable activity trackers. This work also involves delivering structured exercise education to families and youth with T1D over telehealth.
-
Lu Zhang
Postdoctoral Scholar, Endocrinology and Metabolism
BioLu is a postdoctoral research scholar in Dr. Anna Gloyn's Translational Genomics of Diabetes Lab. During her master's and doctoral studies, she focused on epigenomics and single-cell multi-omics analysis, with an emphasis on 3D genomics. Her research included developing Hi-Tag, a chromatin conformation capture technique designed for use with small cell samples. This method provides valuable insights into the organization of chromatin in the cell. She has built strong expertise in combining different types of biological data, including RNA-seq, ATAC-seq, chromatin interaction data, and single-cell data. She has contributed to several research projects as a co-author, including studies that used genome-wide association studies (GWAS) and GTEX data to connect multi-omics data with functional genomics. These experiences have helped her gain a deep understanding of how to integrate different types of genomic data to solve complex biological problems. Currently, Lu is focused on applying her research skills to diabetes.
-
Yanxian Zhang
Postdoctoral Scholar, Endocrinology and Metabolism
BioThrough my academic training and research experience, I have cultivated a strong foundation in engineering and molecular biology. My work involves integrating diverse concepts from disciplines such as chemical engineering, protein engineering, supramolecular chemistry, and biophysics to address complex biomedical challenges. As a graduate student with Dr. Jie Zheng, my research focused on both natural and synthetic macromolecules. My research involved utilizing polymer chemistry to design biocompatible multifunctional hydrogels, as well as investigating the thermodynamics of amyloid proteins associated with neurodegenerative diseases. Leveraging my expertise in thermodynamics and supramolecular chemistry, I contributed to the study of understanding protein misfolding and aggregation. I identified sequence-independent inhibitors to prevent protein misfolding and developed a rational strategy for inhibitor design, enabling cross-interaction activity and the fluorescent detection of amyloids. Driven by a strong interest in translational research, I pursued postdoctoral training here at Stanford School of Medicine. In Dr. Danny Hung-Chieh Chou's lab at Stanford University, I received comprehensive training in peptide engineering and molecular biology. I am dedicated to addressing formulation challenges for insulin with stable ultra-concentrated and ultra-fast properties, aimed at miniaturizing insulin pumps and advancing the next-generation of insulin automatic delivery systems. This work is supported by the JDRF postdoctoral fellowship. Furthermore, I am working on therapeutics development and have successfully developed an insulin derivative that acts as a full insulin receptor antagonist. This development holds promise as a candidate for treating the rare disease of hyperinsulinism. Throughout my postdoctoral training, I have gained proficiency in grant writing, public speaking, and mentoring students. These experiences have significantly strengthened my skills as an independent investigator. Looking forward, my research goal is to develop innovative strategies that support the functionality and delivery of biological therapies.